APEX-AV is a clinical study aimed at evaluating the safety and efficacy of the Company’s AlphaVac Multipurpose Mechanical Aspiration F1885 System in the treatment of acute intermediate-risk pulmonary embolism (PE).
PE represents the third-leading cause of cardiovascular mortality in the United States.1
Learn More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
Engineered with your practice and your patients in mind, The Auryon System is designed with industry-leading technology and features that…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
